NCT06517940View on ClinicalTrials.gov

A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)

Active, not recruitingOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

October 3, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Retinitis Pigmentosa
Trial Locations (1)

02114

Mass Eye and Ear, Boston

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT06517940 - A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP) | Biotech Hunter | Biotech Hunter